Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Jaw Motion in Bruxers
NCT05604729Recruiting
- Sponsor
- Region Västerbotten
- Start
- Sep 2023
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in bruxism (3 arms), sponsored by Region Västerbotten. Primary endpoints: Change of range of motion, Change of envelope of motion and 1 more. Started Sep 2023; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
bruxism
Beyond the preview
Go deeper on NCT05604729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05604729.